Sun Pharma Advanced Research Company Limited is engaged in the research and experimental development on natural sciences and engineering (Pharmacy). The Company operates through Pharmaceuticals Research & Development segment. Its programs include Xelpros, Elepsia XR, Baclofen GRS, Paclitaxel Injection Concentrate for Nanodispersion (Taclantis), Salmeterol - Fluticasone Dry Powder Inhaler (DPI), SUN-K706, Brimonidine OD, Tizanidine ER, Minocycline Topical and SUN-597 Topical. Xelpros is a Benzalkonium Chloride (BAK)-free Latanoprost eye drops developed with its Swollen Micelle Microemulsion (SMM) technology. Elepsia XR is a once-a-day formulation of Levetiracetam, an antiepileptic agent. Baclofen GRS is a once-a-day formulation of Baclofen, a centrally acting, antispasmodic drug. Taclantis is a Cremophor and Albumin free formulation. Its DPI is a premetered, 60 doses, breath activated device to administer combination of Salmeterol and Fluticasone by inhalation.